The Global Elastomeric Infusion Pumps Market Growth Accelerated By Rising Demand For Continuous Drug Delivery
![]() |
Elastomeric Infusion Pumps Market |
Elastomeric Infusion Pumps are drug delivery devices used
for controlled delivery of medications such as antibiotics, analgesics,
chemotherapy drugs, and other drugs. The pumps offer several advantages over
traditional infusion methods including ambulatory mobility as they are small,
lightweight, and easy to carry or wear.
The global Elastomeric Infusion Pumps Market is estimated to
be valued at US$ 446.31 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period
2024 to 2031, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
Technological advancements in elastomeric pump design are expected to be a
major trend in the market over the forecast period. Continuous enhancement and
development of infusion pump functions by incorporating connectivity, control
features, and data sharing capabilities are paving the way for next-generation
smart elastomeric pumps. Key players are launching Bluetooth and Wi-Fi enabled
pumps that allow wireless programming and monitoring of drug delivery schedules
from a smartphone or web portal. This enables real-time patient monitoring and
improves compliance to prescribed medication schedules. These smart pumps also
allow for over-the-air firmware and software upgrades to enhance their
functional abilities over time without requiring physical servicing or visit to
a healthcare facility.
Segment Analysis
The global elastomeric infusion pumps market is dominated by patient-controlled
analgesia pumps segment. These pumps are small battery-powered infusion devices
used during post-operative pain management that allow patients to
self-administer pre-set bolus doses of analgesics based on their self-assessed
pain levels. Patient-controlled analgesia pumps ensure superior pain relief
compared to traditional intermittent scheduled injections, enabling earlier
mobilization and a more comfortable recovery process for patients.
Key Takeaways
The global
elastomeric infusion pumps market analysis is expected to witness high
growth over the forecast period of 2024 to 2031 supported by rising aging
population and increasing incidence of chronic diseases worldwide. The global
Elastomeric Infusion Pumps Market is estimated to be valued at US$ 446.31 Bn in
2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 to
2031.
Regional analysis:
North America region
currently dominates the market owing to rapidly growing geriatric population
and higher adoption of advanced medical devices in the region. Europe is also a
major market supported by availability of favorable reimbursement policies and
healthcare infrastructure. Asia Pacific region is expected to witness fastest
growth over the coming years due to improving healthcare access, growing
medical tourism industry, and increasing expenditures on healthcare in
countries like China and India.
Key players:
Key players operating in the elastomeric infusion pumps
market are Sika AG, BASF SE, Fosroc International Limited, Saint-Gobain Weber,
The Euclid Chemical Company, Dayton Superior Corporation, WR Meadows, Specified
Technologies Inc, TCC Materials and EMSEAL Joint Systems Ltd. These leading
manufacturers are focusing on new product launches and expanding regional
presence to strengthen their market position.
Get more insights on
this topic: https://www.newswirestats.com/elastomeric-infusion-pumps-market-industry-insights-trends-elastomeric-infusion-pumps-market/
Comments
Post a Comment